The role of profilin-1 in endothelial cell injury induced by advanced glycation end products (AGEs)

Cardiovascular Diabetology

Volumn 12, Issue 1, 2013, Pages

  Li, Zhenyu ^a   Zhong, Qiaoqing ^b   Yang, Tianlun ^a   Xie, Xiumei ^a   Chen, Meifang ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b THE FIRST PEOPLE S HOSPITAL OF CHENZHOU   (China)

Author keywords

Advanced glycation end products (AGEs); Cytoskeletal rearrangement; Endothelial cells; Nuclear factor kappa B (NF B); Profilin 1; Protein kinase C (PKC); Reactive oxygen species (ROS)

Indexed keywords

2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; 3 (4 METHYLPHENYLSULFONYL) 2 PROPENENITRILE; ADVANCED GLYCATION END PRODUCT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; MESSENGER RNA; N(G),N(G) DIMETHYLARGININE; NITRIC OXIDE; PROFILIN; PROFILIN I; PROTEIN KINASE C; REACTIVE OXYGEN METABOLITE; SERUM ALBUMIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ACTIN FILAMENT; ARTICLE; CELL DAMAGE; CONTROLLED STUDY; CYTOPLASM; CYTOSKELETON; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; ENDOTHELIUM INJURY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; UMBILICAL VEIN ENDOTHELIAL CELL; WESTERN BLOTTING;

ANTIOXIDANTS; ARGININE; CELLS, CULTURED; CYTOSKELETON; DOSE-RESPONSE RELATIONSHIP, DRUG; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; NF-KAPPA B; NITRIC OXIDE; PROFILINS; PROTEIN KINASE C; PROTEIN KINASE INHIBITORS; REACTIVE OXYGEN SPECIES; RNA INTERFERENCE; RNA, MESSENGER; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSFECTION;

EID: 84884954084     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-12-141     Document Type: Article

References (38)

1. Ceriello A. The emerging challenge in diabetes: the "metabolic memory" Vascul Pharmacol 2012, 57:133-138. 10.1016/j.vph.2012.05.005, 22609133.
2. Genuth S, Sun W, Cleary P, Sell DR, Dahms W, Malone J, Sivitz W, Monnier VM, DCCT Skin Collagen Ancillary Study Group Glycation and carboxymethyllysine levels in skin collagen predict the risk of future 10-year progression of diabetic retinopathy and nephropathy in the diabetes control and complications trial and epidemiology of diabetes interventions and complications participants with type 1 diabetes. Diabetes 2005, 54:3103-3111. 10.2337/diabetes.54.11.3103, 2622724, 16249432, DCCT Skin Collagen Ancillary Study Group.
3. Kiuchi K, Nejima J, Takano T, Ohta M, Hashimoto H. Increased serum concentrations of advanced glycation end products: a marker of coronary artery disease activity in type 2 diabetic patients. Heart 2001, 85:87-91. 10.1136/heart.85.1.87, 1729572, 11119472.
4. Ceriello A, Ihnat MA, Thorpe JE. The "metabolic memory": is more than just tight glucose control necessary to prevent diabetic complications?. J Clin Endocrinol Metab 2009, 94:410-415. 10.1210/jc.2008-1824, 19066300.
5. Guo ZJ, Niu HX, Hou FF, Zhang L, Fu N, Nagai R, Lu X, Chen BH, Shan YX, Tian JW, Nagaraj RH, Xie D, Zhang X. Advanced oxidation protein products activate vascular endothelial cells via a RAGE-mediated signaling pathway. Antioxid Redox Signal 2008, 10:1699-1712. 10.1089/ars.2007.1999, 18576917.
6. Bogatcheva NV, Garcia JG, Verin AD. Molecular mechanisms of therombin-induced endothelial cell permeability. Biochemistry (Mosc) 2002, 67:75-84. 10.1023/A:1013904231324, 11841342.
7. Romeo G, Frangioni JV, Kazlauskas A. Profilin acts downstream of LDL to mediate diabetic endothelial cell dysfunction. FASEB J 2004, 18:725-727.
8. Romeo GR, Moulton KS, Kazlauskas A. Attenuated expression of profilin-1 confers protection from atherosclerosis in the LDL receptor null mouse. Circ Res 2007, 101:357-367. 10.1161/CIRCRESAHA.107.151399, 17615372.
9. Romeo GR, Kazlauskas A. Oxysterol and diabetes activate STAT3, and control endothelial expression of profilin-1 via OSBP1. J Biol Chem 2008, 283:9595-9605. 10.1074/jbc.M710092200, 18230613.
10. Wang J, Liu H, Chen B, Li Q, Huang X, Wang L, Guo X, Huang Q. RhoA/ROCK-dependent moesin phosphorylation regulates AGE-induced endothelial cellular response. Cardiovasc Diabetol 2012, 11:7. 10.1186/1475-2840-11-7, 3280169, 22251897.
11. Guo XH, Huang QB, Chen B, Wang SY, Li Q, Zhu YJ, Hou FF, Fu N, Brunk UT, Zhao M. Advanced glycation end products induce actin rearrangement and subsequent hyperpermeability of endothelial cells. APMIS 2006, 114:874-883. 10.1111/j.1600-0463.2006.apm_372.x, 17207088.
12. Vandenbroucke E, Mehta D, Minshall R, Malik AB. Regulation of endothelial junctional permeability. Ann N Y Acad Sci 2008, 1123:134-145. 10.1196/annals.1420.016, 18375586.
13. Basta G, Schmidt AM, De Caterina R. Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes. Cardiovasc Res 2004, 63:582-592. 10.1016/j.cardiores.2004.05.001, 15306213.
14. Rojas A, Morales MA. Advanced glycation and endothelial functions: a link towards vascular complications in diabetes. Life Sci 2004, 76:715-730. 10.1016/j.lfs.2004.09.011, 15581904.
15. Seki N, Hashimoto N, Taira M, Yagi S, Yoshida Y, Ishikawa K, Suzuki Y, Sano H, Horiuchi S, Yoshida S, Sakurai K, Yagui K, Makino H, Saito Y. Regulation of Src homology 2-containing protein tyrosine phosphatase by advanced glycation end products: the role on atherosclerosis in diabetes. Metabolism 2007, 56:1591-1598. 10.1016/j.metabol.2007.06.029, 17950112.
16. Stirban A, Negrean M, Stratmann B, Gawlowski T, Horstmann T, Götting C, Kleesiek K, Mueller-Roesel M, Koschinsky T, Uribarri J, Vlassara H, Tschoepe D. Benfotiamine prevents macro- and microvascular endothelial dysfunction and oxidative stress following a meal rich in advanced glycation end products in individuals with type 2 diabetes. Diabetes Care 2006, 29:2064-2071. 10.2337/dc06-0531, 16936154.
17. Negrean M, Stirban A, Stratmann B, Gawlowski T, Horstmann T, Götting C, Kleesiek K, Mueller-Roesel M, Koschinsky T, Uribarri J, Vlassara H, Tschoepe D. Effects of low- and high-advanced glycation endproduct meals on macro- and microvascular endothelial function and oxidative stress in patients with type 2 diabetes mellitus. Am J Clin Nutr 2007, 85:1236-1243.
18. Soro-Paavonen A, Zhang WZ, Venardos K, Coughlan MT, Harris E, Tong DC, Brasacchio D, Paavonen K, Chin-Dusting J, Cooper ME, Kaye D, Thomas MC, Forbes JM. Advanced glycation end-products induce vascular dysfunction via resistance to nitric oxide and suppression of endothelial nitric oxide synthase. J Hypertens 2010, 28:780-788. 10.1097/HJH.0b013e328335043e, 20186099.
19. Li H, Zhang X, Guan X, Cui X, Wang Y, Chu H, Cheng M. Advanced glycation end products impair the migration, adhesion and secretion potentials of late endothelial progenitor cells. Cardiovasc Diabetol 2012, 11:46. 10.1186/1475-2840-11-46, 3403843, 22545734.
20. Yamagishi S, Ueda S, Nakamura K, Matsui T, Okuda S. Role of asymmetric dimethylarginine (ADMA) in diabetic vascular complications. Curr Pharm Des 2008, 14:2613-2618. 10.2174/138161208786071326, 18991678.
21. Tarnow L, Hovind P, Teerlink T, Stehouwer CD, Parving HH. Elevated plasma asymmetric dimethylarginine as a marker of cardiovascular morbidity in early diabetic nephropathy in type 1 diabetes. Diabetes Care 2004, 27:765-769. 10.2337/diacare.27.3.765, 14988299.
22. Sibal L, Agarwal SC, Home PD, Boger RH. The role of asymmetric dimethylarginine (ADMA) in endothelial dysfunction and cardiovascular disease. Curr Cardiol Rev 2010, 6:82-90. 10.2174/157340310791162659, 2892080, 21532773.
23. Ojima A, Ishibashi Y, Matsui T, Maeda S, Nishino Y, Takeuchi M, Fukami K, Yamagishi S. Glucagon-like peptide-1 receptor agonist inhibits asymmetric dimethylarginine generation in the kidney of streptozotocin-induced diabetic rats by blocking advanced glycation end product-induced protein arginine methyltranferase-1 expression. Am J Pathol 2013, 182:132-141. 10.1016/j.ajpath.2012.09.016, 23159951.
24. Ando R, Ueda S, Yamagishi S, Miyazaki H, Kaida Y, Kaifu K, Yokoro M, Nakayama Y, Obara N, Fukami K, Takeuchi M, Okuda S. Involvement of advanced glycation end product-induced asymmetric dimethylarginine generation in endothelial dysfunction. Diab Vasc Dis Res 2013, 10:436-441. 10.1177/1479164113486662, 23766377.
25. Wang LJ, Yu YH, Zhang LG, Wang Y, Niu N, Li Q, Guo LM. Taurine rescues vascular endothelial dysfunction in streptozocin-induced diabetic rats: correlated with downregulation of LOX-1 and ICAM-1 expression on aortas. Eur J Pharmacol 2008, 597:75-80. 10.1016/j.ejphar.2008.08.031, 18796303.
26. Moldovan NI, Milliken EE, Irani K, Chen J, Sohn RH, Finkel T, Goldschmidt-Clermont PJ. Regulation of endothelial cell adhesion by profilin. Curr Biol 1997, 7:24-30. 10.1016/S0960-9822(06)00024-8, 9024619.
27. Dardik R, Savion N, Gal N, Varon D. Flow conditions modulate homocysteine induced changes in the expression of endothelial cell genes associated with cell-cell interaction and cytoskeletal rearrangement. Thromb Haemost 2002, 88:1047-1053.
28. Ding Z, Lambrechts A, Parepally M, Roy P. Silencing profilin-1 inhibits endothelial cell proliferation, migration and cord morphogenesis. J Cell Sci 2006, 119:4127-4137. 10.1242/jcs.03178, 16968742.
29. Caglayan E, Romeo GR, Kappert K, Odenthal M, Südkamp M, Body SC, Shernan SK, Hackbusch D, Vantler M, Kazlauskas A, Rosenkranz S. Profilin-1 is expressed in human atherosclerotic plaques and induces atherogenic effects on vascular smooth muscle cells. PLoS One 2010, 5:e13608. 10.1371/journal.pone.0013608, 2963617, 21049052.
30. Romeo GR, Pae M, Lee J, Shoelson SE. Profilin-1 haploinsufficiency protects against obesity-associated glucose intolerance and preserves adipose tissue immune homeostasis. Diabetes 2013, Epub ahead of print.
31. Hirose A, Tanikawa T, Mori H, Okada Y, Tanaka Y. Advanced glycation end products increase endothelial permeability through the RAGE/Rho signaling pathway. FEBS Lett 2010, 584:61-66. 10.1016/j.febslet.2009.11.082, 19944695.
32. Wang Z, Guo X, Liu X, Wang J, Wang L, Huang Q. The morphological changes of vascular endothelial cadherin in human umbilical vein endothelial cells induced by advanced glycation end products. Chin J Arterioscler 2008, 16:505-509.
33. Otero K, Martínez F, Beltrán A, González D, Herrera B, Quintero G, Delgado R, Rojas A. Albumin-derived advanced glycation end-products trigger the disruption of the vascular endothelial cadherin complex in cultured human and murine endothelial cells. Biochem J 2001, 359:567-574. 10.1042/0264-6021:3590567, 1222177, 11672430.
34. Nishikawa T, Edelstein D, Du XL, Yamagishi S, Matsumura T, Kaneda Y, Yorek MA, Beebe D, Oates PJ, Hammes HP, Giardino I, Brownlee M. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 2000, 404:787-790. 10.1038/35008121, 10783895.
35. Mamputu JC, Renier G. Signalling pathways involved in retinal endothelial cell proliferation induced by advanced glycation end products: inhibitory effect of gliclazide. Diabetes Obes Metab 2004, 6:95-103. 10.1111/j.1462-8902.2004.00320.x, 14746574.
36. Rosen P, Nawroth PP, King G, Moller W, Tritschler HJ, Packer L. The role of oxidative stress in the onset and progression of diabetes and its complications: a summary of a congress series sponsored by the UNESCOMCBN, the American diabetes association and the German diabetes society. Diabetes Metab Res Rev 2001, 17:189-212. 10.1002/dmrr.196, 11424232.
37. Romeo G, Liu WH, Asnaghi V, Kern TS, Lorenzi M. Activation of nuclear factor-kappaB induced by diabetes and high glucose regulates a proapoptotic program in retinal pericytes. Diabetes 2002, 51:2241-2248. 10.2337/diabetes.51.7.2241, 12086956.
38. Niwa K, Sakai J, Karino T, Aonuma H, Watanabe T, Ohyama T, Inanami O, Kuwabara M. Reactive oxygen species mediate shear stress-induced fluid-phase endocytosis in vascular endothelial cells. Free Radic Res 2006, 40:167-174. 10.1080/10715760500474287, 16390826.